Combination of JAK2 Inhibitor and Erythropoiesis-stimulating Agent in Myelofibrosis

Clinical trial NCT03208803 · COMPLETED

Trial details

NCT number: NCT03208803
Sponsor: Centre Hospitalier Annecy Genevois
Status: COMPLETED
Study type: OBSERVATIONAL

Myelofibrosis; Anemia

Start date: 2016-05-01
Primary completion: 2016-12-31
Enrollment: 65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.